773872-61-0 Usage
Uses
Used in Organic Synthesis:
(3'-TRIFLUOROMETHYLBIPHENYL-3-YL)-METHANOL is used as a building block for the creation of more complex molecules, playing a crucial role in advancing the field of organic synthesis.
Used in Pharmaceutical Synthesis:
In the pharmaceutical industry, (3'-TRIFLUOROMETHYLBIPHENYL-3-YL)-METHANOL is used as a precursor for the development of new drugs, contributing to the discovery and production of innovative medicinal compounds.
Used in Agrochemical Development:
(3'-TRIFLUOROMETHYLBIPHENYL-3-YL)-METHANOL is utilized as a starting material in the synthesis of agrochemicals, aiding in the production of substances that help protect and enhance crop yields.
Used in Materials Science:
(3'-TRIFLUOROMETHYLBIPHENYL-3-YL)-METHANOL is also employed in materials science applications, where it serves as a precursor to develop new materials with specific properties for various uses.
Check Digit Verification of cas no
The CAS Registry Mumber 773872-61-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,3,8,7 and 2 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 773872-61:
(8*7)+(7*7)+(6*3)+(5*8)+(4*7)+(3*2)+(2*6)+(1*1)=210
210 % 10 = 0
So 773872-61-0 is a valid CAS Registry Number.
773872-61-0Relevant articles and documents
IMIDAZOTHIADIAZOLE AND IMIDAZOPYRIDAZINE DERIVATIVES AS PROTEASE ACTIVATED RECEPTOR 4 (PAR4) INHIBITORS FOR TREATING PLATELET AGGREGATION
-
Paragraph 00129, (2013/11/18)
The present invention provides imidazothiadiazole compounds of Formula (I); Wherein W,Y, R0, R2, R4, Ra, Rb, X1, X2, X3 and X4 are as defined herein,, or a stereoisomer, tautomer, pharmaceutically acceptable salt, prodrug ester or solvate form thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of platelet aggregation and thus can be used as medicaments for treating or preventing thromboembolic disorders.
INHIBITORS OF FATTY ACID AMIDE HYDROLASE
-
Page/Page column 173-174, (2008/12/05)
The present invention provide compounds, and pharmaceutical compositions thereof, encompassed by the formulae (I), (II) or (III). The present invention also provides methods for treating FAAH mediated disease, disorder or condition by administering a ther
